Category Archives: Human Longevity

A senior editor once told a nervous new recruit that to write likeTheEconomist, you just pretend you are God.

Wilson, who died of dysentery in 1860, is less remembered than his son-in-law and successor asEconomisteditor, Walter Bagehot. Zevin does not share a sentimental view of this prolific writer and editor as the greatest Victorian (as the historian Jacques Barzun described him). More pragmatic than Wilson, Bagehot did favor a permanent graduated income tax and, in his 1873 book Lombard Street, the idea of a central bank as a lender of last resort. But his love of finance clashed with democratic demands. He wanted a government that was maximally compatible with the needs of finance. (When he was feeling sad, Bagehot is reported to have made a habit of going to the bank to run his hands through heaps of coins.) The thesis of his bookThe English Constitution, written in 1867, was that the British government worked not because of the separation of powers, but because the real work of governing was done by the Cabinet while the monarchy put on a performance of governing to please what he called the vacant many. Every person has a right to so much power, wrote Bagehot, as he can exercise without impeding any other person who would more fitly exercise such powera view far more aristocratic than libertarian. In all cases it must be remembered, he declared, that a political combination of the lower classes as such and for their own objects, is an evil of the first magnitude.

Bagehots belief in the British ruling classs special fitness also extended to questions of empire. Both Wilson and Bagehot were broadly believers in liberal empire, and Wilson approved, for example, of the opening of China by violence. (In 1857, the paper wrote, We may regret war but we cannot deny that great advances have followed in its wake.) Bagehot, for his part, thought the British the most enterprising, the most successful, and in most respects the best, colonists on the face of the earth.The Economistcelebrated British imperialism above others, assuming its good intentions and that it worked to promote trade. But it rarely criticized: It stayed silent on the discovery of British-run concentration camps in the Second Boer War, for example. Zevin argues that TheEconomists pro-finance position necessarily made it a cheerleader for empire, since empire was the framework within which wealth was being created.

But liberalism has many currents, and in response to imperial abuses and demands for social reform, in the early twentieth century The Economist entered a new period.Its editorial line acted as a kind of barometer of liberal conventional wisdom, responding to the atmospheric pressure of world events. Editor Francis Hirst, who took the top job in 1907, held, much like Hobson, that the scramble for Africa was the result of financial imperialism, rather than the means to pass on the supposed blessings of civilization. Hirst condemned military aggression, arguing that reducing spending on arms was the only way to carry out needed social reforms while keeping taxes low. Perhaps Hirsts statement that the British Constitution was only a mask over the face of plutocracy was not so analytically distinct from Bagehot, but Hirst at least meant it as a criticism.

Hirst was ultimately let go for his opposition to World War I, but the publication continued to reflect the rising influence of the Labour Party, and the more radical demands of its time. Many students of Keynes wrote for the paper during the Great Depression, and Douglas Jay, later a Labour member of Parliament, even wrote a book calledThe Socialist Casein 1937 while on staff.The Economisthardly abandoned its free-trade principles: It felt that, under the circumstances, it was essential to help ensure that the Labour Party understood the needs of the bankers, and how they might be properly integrated into a mixed economy.The Economisteven endorsed the Beveridge Report in 1942, which laid the foundations for the postwar welfare state and the National Health Service in Britain. It was in this period, from 1938 to 1956, under the editorship of Geoffrey Crowther, that the readership expanded significantly, and the paper developed its signature style: witty and pragmatic, staking out what Crowther described as the extreme center.

Link:
The World The Economist Made - The New Republic

Geoff Burke-USA TODAY Sports

Hey everyone, its our final Mailbag of 2019. A rare departure into sentimentality but here comes the cut and paste from years past: If you get half as much pleasure (guilty, to be sure) from reading this column as I get from writing it, we're all doing pretty well. Your questions and observations are, reliably, thoughtful and informed and passionate, and please know that every last oneeven the ones wishing me incurable cold soresare read. Think of this as a sincere invitation to belly up to the bar in 2020 and we can resume the conversations. Happy holidays, Happy New Year.

I am flattered and humbled by how many of you have requested to receive the column via email each week, newsletter style. Offer still holds.

A few of you asked about Sundays 60 Minutes piece. Heres a link.

If youre interested in a holiday-time contribution, consider:

a) Andrea Jaeger Little Star Foundation b) the MaliVai Washington Youth Foundation c) NYJTL

Onward

Have a question or comment for Jon? Email him at jon_wertheim@yahoo.com or tweet him @jon_wertheim.

Jon, I heard you mention on the podcast that this was the end of the decade, the 2010s. Maybe because weve all been distracted with so many world events, I hadnt really thought of that. Overall, do you think it was a good decade for tennis?Charles, London

Imagine its December of 2009 and, after putting on your Carnac hat, you said, Behold! I can see into the future. In ten years from now.

Serena Williams will be the womens tennis center of gravity.Nadal, Djokovic, and Federer will be 1-2-3.The field will be getting increasingly older....More and more minorities, especially on the womens side, will follow the lead of the Williams sisters and break through.Tennis will be subject to relentless global forces, a net positive, but it will mean power will not be concentrated in one place. The U.S., for instance, will go 0-40 on the mens side.Rampant conflicts of interests and self-interested turf wars will stunt the sports growth. Your audience would doubtlessly have heard these pronouncements and responded, So, in other words, nothing changed.

Now imagine another soothsayer. Wait, I can see tennis in December 2019! Canada will be a superior tennis power to the U.S.! Top players will compete into their late 30s without an appreciable dropoff.Pete Sampras will be ranked fourth on the all-time Slam list. There will be a doping scandal involving a top player, and though more about sloppiness than ill-intent, it will still be damaging to the brand. And that player will be: Maria Sharapova.Spain will have won the Davis Cup in Madrid: and what a spirited weeklong, single-site competition it will have been. All of which is to say: plenty changed in ten years.

Overall, Id contend that it was a terrific decade for the sport. It took advantage of globalization, of the great virtue of both genders, and of star power. The four thoroughbredsthe Big Three and Serena, of coursewere still high in the saddle as the decade drew to a close. And everyone benefitted from the longevity.

In many ways, tennis is so well-poised for the future. Its already penetrated markets other industries arent even sniffing. (An Australian just beat a Ukrainian to earn $4.5 million by winning a tournament...in China.) The sport benefits from changes to media and technology and communications. The sport benefits from two genders playing simultaneously. But in this star-driven world, tennis also needs to consider a future without the four mainstays in the workforce. In a mobile world it needs to consider how to compete not just with other sports but with other entertainment. In a world where inefficiency gets punished, it will pay a bigger price than ever for conflicts and sloppy governance and dinosaurs in the executive offices.

All of which is to say.tennis breezed though the 2010s without much sweating. Now it needs to come back strong for the 2020s, prepared to get its serve broken a few times and take some setbacks but still prevail.

Whats your favorite Wozniacki memory?! Australian Open in 2018 comes to mind, but Im also tempted to go with her 2014 U.S. Open win against Sharapovaa year in which Sharapova was playing very well (won French) and Wozniacki was back on the uptick. That win underscored Wozniackis grit and ability to run forever. Her performances in the 2017 (won) and 2014 (finals) year-end championships were also pretty epic. I really like her. She has a great vibe about her from a fans perspectiveboth on and off the court. Would love to hear your thoughts!Damian, Melbourne, Australia

Obviously the 2018 Australian Open, a career highlight that enabled her to shed dreaded the Best player never to have won a Major costume. But you know what story was underrated? Her running of the New York City Marathon. She was in the middle of her career25 years old and ranked in the top tenand trained to run a marathon that she completed in 3:26:33! A) what a strong message this sends about the athleticism and durability and conditioning of WTA players; B) what a strong message this sends about independence and autonomy. Sometimes we can do things because we want to; even if they fly in the face of conventional professional wisdom.

A personal story, that I fear is going to sound unseemly and humblebraggy, but here goes. Wozniacki and I are not friends, but friendly. I think I mentioned that her apartment in New York is a few blocks away from mine. We run into each other in the neighborhood and, of course, at events. Last year, she popped into my office at CBS and I showed her around. After she left, a colleague asked nervously, Are we going to hire that woman?

What woman?

The woman you were interviewing.

Interviewing?

That blond woman.

Oh, no. Shes a tennis player. She already has a job.

Tennis player? Shes came across so professional and was so friendly, I figured she was gunning for a job here.

Nope, shes a tennis player.

Is she any good?

Jon: A few weeks ago, you wrote, "Sports are predicated on the idea that the competition is honest. If not, if the integrity is being undermined, the whole Jenga tower collapses. Mostly this means doping and paying college athletes and stealing signs and, generally, being the Houston Astros."

After I stopped cracking up at the Houston Astros, I noticed the college athlete comment. I guess this means you're against paying college athletes? Care to share your reasoning? I'm still trying to make up my mind about the issue. Paul

No, no, noI am fully, squarely, unambiguously in favor of paying college athletes. College sports have become morally indefensible. You have assistant coaches in college football making seven-figure salaries. Yet the athleteswho are the ones generating the revenue, putting themselves at risk and often the least likely students on campus to graduateare not being compensated? One day, we will be telling our grandkids about this economic injustice and shrugging when asked how this was allowed to persist.

My point was this: if one athlete is doping and the other is not, the tower collapses. If one team is paying its athletes and the other is not, the tower collapses. If the Patriots are secretly video-taping and the other teams arent, the tower collapses. We can debate which rules are fair and unfair and should be changed. But if one side complies with the rules and the other doesnt, the integrity of fair competition is undermined.

I happened to run across a video on YouTube of Gabriella Sabatini and Arantxa Sanchez-Vicario. Looking back, it seemed like Sabatini came out of the gates faster and should have had the more successful career of the twowasnt she the only player to defeat Graf three times in 198889? Sabatini didnt have a slouch of a careerone Slam and some Slam finals. But no No. 1 ranking or multiple slams like ASV, who seemed to have a more limited game. What do you attribute to the difference in their careers? The power of hyphenated last names? Do you see any parallels to a couple of players today?PN

If it were about the power of the hyphenated name, a junior player named Rafael Nadal-Parera would have made a splash. As for your question, its an interesting comparison of contemporaries who came with very different skill sets and governing principles. As is the case in most contexts, style versus substance is too crass. But ASV played at an uncommon level of competitive resolve, which enabled her to have the superior career, both to Sabatini and to everyone else in her era, save Steffi Graf and Monica Seles.

I just read an extraordinary article on Federer. Extraordinary to me, because I had no idea of all these hidden machinations and power brokering by my favorite current player. So, my question is this: is this article being fair? Is it correct? Can Federer really not "even drink tea without a stratagem?"

Or, are the arguments just correlations leading to causation? "2 + 2 = 11" types?!! In other words, is Federer's goody-goody persona a mere smokescreen, or, is the article just smoke without a fire? Insider perspective needed! Arun Narayanan, Lappeenranta, Finland

Is none of the above an option?

Know that Im in the tank for Simon Briggsa journalist who does rigorous and unimpeachable workand think the story is completely legitimate and fair. I also think Federer is well within his rights to take a stake in the sport. In fact, I would almost take the opposite angle: if Federerage 38 and armed with moral authorityDID NOT wield his moral authority, it would be deeply disappointing.

Tennis is in desperate need of conflicts disclosure. It would be great if everyone in the sport revealed where their proverbial bread was buttered and simply spoke the truth. (In Federers case: The Davis Cup and even, to some extent, this cockamamie ATP Cup are both trying to take my market share; so the idea that I would play either is as preposterous as my wearing jorts to the Met Gala.)

But I dont read that story and see anything inconsistent, much less unethical. Just a guy, nearing the end of his career, exerting some well-earned authority, and taking the equivalent of equity stakes in some ventures.

My first time writing to you. I am intrigued. There is a tennis lineswoman, she looks Asian and is short, whom I see at many big matches. She is the only tennis linesman or woman I recognize from year to year. I first noticed her when she called the footfault on Serena Williams in the semifinal of the U.S. Open in 2009, was threatened by Serena, and reported it to the chair umpire. Serena lost the match to Kim Clijsters as a result. I have seen this lineswoman on TV many times since, at big matches (I guess because those are televised), including matches in 2019.Marika in Maryland

Here comes Gayle Bradshaw of the ATP, one of tennis good guys, to explain:

Officials, including line umpires, are not allowed to speak to the press unless permission is granted by the governing authority for that event. This would rarely be authorized, but when it is the subject matter would be limited to how they got into officiating or a human interest angle. Nothing about players, matches, controversial calls, other officials is allowed even if an interview was authorized. They can have social media presence but the same prohibitions would apply to anything they post. Speaking about these prohibited subjects would place the official in violation of the Code for Officials and could face sanction ranging from a warning to a loss of their certification. They could also fall afoul of the Tennis Integrity Program if they were to post anything that could be interpreted as inside information.

Who hires them? It is the responsibility of the tournament organizers. They hire a chief of officials who in turn hires the line umpires and additional chair umpires needed for the event. In the US for ATP events, the tournaments contract for their officials through the ATP and we have a Chief we keep on retainer who manages this program. Line umpires are selected on a rating system where they are graded on their performance at every match and then are given an overall grade. Acceptance to events is based similar to the way players are accepted to events based upon their ranking. We also give the USTA a few spots (wild cards) to place up-and-coming officials who would not have an established rating yet.

Once retired from officiating, an official would be free to write a book and several officials have done so. Charlie Beck, former MTC Supervisor; Alan Mills, fmr Wimbledon Referee are some of the more well-known but there are others also. Both of these books were released after the officials retired from officiating.

Robin Montgomerya 15-year old from D.C.and Argentinas Thiago Tirante triumph at the Orange Bowl. Colette Lewis has you covered. Of course she does.

Hold your nose, here comes a match-fixing scandal.

Thanks,reader Cesar Torres.Heres an interesting academic read on the WTAs family leave policy.

Who double-bageled Roger Federer?

From Chris Jordan: I noticed you posted about a book about pro tennis by Peter Underwood. A few months ago, I released a book on pro tennis, which contains the largest collection of pre-open era pro tennis results ever assembled (it contains over 420 pages of results, plus a narrative section of over 110 pages). It took me many months of detailed research. It is called The Professional Tennis Archive and is available from amazon worldwide. The Tennis Hall of Fame library and Wimbledon library have copies of it. I would be grateful if you could post a link to it.

International Tennis Federation (ITF) President, David Haggerty, has been nominated as a candidate by the International Olympic Committee (IOC) to become an IOC member as an International Federation representative. The elections are due to take place on 10 January 2020 in Lausanne, Switzerland.

Here is the original post:
Mailbag: Looking Back on the 2010s Decade in Tennis and Ahead to the Future - Sports Illustrated

Traditional recycling is the greatest example of modern-day greenwashing.

Recycling is championed as the strategy to enable a cleaner, healthier world by those businesses that have profited the most from the extractive, take-make-waste economy. In reality, it is merely a cover to continue business as usual. Corporations espouse the efficacy of recycling via hollow "responsibility commitments" in order to avoid examination of the broader negative consequences that their products and business models have wrought.

Recycling is good for one thing, though it helps us dodge the responsibility of our rampant and unsustainable consumption.

Now is the time to challenge our core assumptions of the global waste management and recycling industry. After nearly 50 years of existence, recycling has proven to be an utter failure at staving off environmental and social catastrophe. It neither helps cool a warming planet nor averts ecosystem destruction and biodiversity loss.

This house of cards is beginning to tumble. In the past two years, several end markets for materials thought to be readily recyclable plastics, glass, cardboard even low-quality aluminum have evaporated. Chinas recent ban on foreign waste imports places the unsustainability of our material management markets front and center. Other countries have followed Chinas lead: Malaysia and the Philippines shipped thousands of tons of waste back to the United States, United Kingdom and Canada, shattering any illusion of the useful blue bin.

After nearly 50 years of existence, recycling has proven to be an utter failure at staving off environmental and social catastrophe.

Why is this happening? Simply put, the global recycling markets have relied on aggressive and disingenuous marketing, exploitative labor practices and global energy prices to remain competitive. At risk of oversimplification, recycling cannot work if it is more profitable to produce goods from virgin materials than recycled ones. As Stiv Wilson from the Story of Stuff put it: "if you want to stop plastic going into the ocean in Indonesia, you need to ban fracking in the Ohio River Valley." The low price of petroleum, coupled with stricter international material management policies, means that ineffective recycling markets are here to stay unless systemic change occurs.

Not only is recycling completely ineffective, it is directly contributing to global health degradation and associated societal injustices.

Where recycling is conducted, the aggregation, separation and reconstruction of materials and products is primarily done using low-cost labor in China and Southeast Asia. This workforce is consistently exposed to dangerous working conditions and toxic chemicals for minimal pay. The injustices of the exploitative labor system that powers the global waste and recycling system are rarely (if ever) factored into the equation. The result is that the true cost of our current material management system is hidden.

Even in the United States, recycling workforce conditions are bleak. During my time inspecting a U.S. material recovery facility (MRF), I was almost severely injured by an improperly locked out piece of machinery called a downstroke baler. The machines massive metal door burst open with the kinetic force of an elephant as I was standing in an unmarked blast zone. Luckily, just as the 1,000-pound hunk of metal started to swing, I took a half a step back and ended up only feeling wind on my face. I was lucky to come away physically unscathed and am privileged to no longer inspect such facilities for a living.

Not everyone has the ability to opt out. The top global waste management corporations purposefully shift these environmental and social risks off their balance sheet to those that cannot afford to say no, a practice reminiscent of food brands refusal to take responsibility for the factory farms that supply their packing operations. The recycling industrys foundation has been built on an opaque, inequitable labor system that consistently exposes a global work force and its communities to dangerous and toxic conditions. This alone should call into question its efficacy.

Perhaps most important, recycling has become a distraction during a time in desperate need of collective urgency and focus. It continues to perpetuate the faade that society can consume with abandon and without consequence. The IPCC estimates we have 10 to 30 years to act if we are to stave off the worst scenarios of global climate change and biodiversity loss. In this all-hands-on-deck moment, recycling initiatives continue to siphon a disproportionate amount of public goodwill, entrepreneurial focus and investment dollars away from meaningful solutions.

We need to implement strategies and invest in existing technologies that can help solve the root causes of climate change and pollution. These solutions fit into two buckets: circular design and green chemistry.

Circular design

Lets not mince words we have a consumption problem. We must dramatically reduce the number of materials and products we consume through design and education and rid ourselves of our reliance on the blue bin. Products should be designed for longevity, advanced disassembly and reuse rather than obsolescence. Complementary policies need to protect a consumers right to repair while enacting attainable extended producer responsibility.

As a society, we need to untether happiness from the act of purchasing goods and embrace business models that promote higher resource use, reuse and true repurposing. Product manufacturers can take inspiration from the natural world to create products designed to optimize for human happiness and environmental health using resources such as IDEOs Circular Design Guide and MBDCs Cradle-to-Cradle protocol. Several organizations are putting these ideas into practice including Metabolic, Fashion for Good and ReFED. Technologies such as Algramo, Vessel, Yerdle, Trumans and Loop can help consumers participate in this journey as well.

Green chemistry

Recycling materials that are inherently toxic means that were simply giving a dangerous substance another chance to poison the environment and our bodies. We must endeavor to make products from safer materials using non-hazardous chemicals and restorative manufacturing processes.

The "bio-economy" aims to make use of chemicals and materials that are readily found in nature, improve ecosystem health where production occurs, and eliminate toxic pollutants regardless of how materials and products are managed at end of use. Organizations such as GC3, Materiom, SaferMade and The Biomimicry Institute are leading the transition.

Unfortunately, corporate responsibility strategies continue to be dominated by traditional recycling initiatives and little else. It is less risky to double down on recycling rather than invest in the strategies outlined above.

The Alliance to End Plastic Waste, an NGO created by the major petrochemical manufacturers in 2018, is an example of how organizations are muddying the waters. The organization will commit to anything other than those solutions that target the root causality. They're simultaneously promising beach cleanups, while its key members including Shell, ExxonMobil and SABIC announce plans to build new multi-billion-dollar polyethylene and petrochemical plants that produce the inexpensive, toxic products that wash up on those same beaches.

The organizations that profit from exploitative recycling business models have a massive economic conflict of interest in shifting toward a fundamentally different system that promotes circular design and green chemistry. Their shareholders will not allow it, so theyll continue investing in peddling the lie that is modern day recycling.

Unfortunately, we have run out of time to entertain business as usual. If we infuse this discussion with the urgency that our polluted ecosystems demand of us, it becomes apparent that squeezing efficiency from the ineffective and exploitative system that is recycling is utterly absurd.

To borrow from Ellen MacArthur, one of the most prominent voices in the circular economy: "Were not going to recycle our way out of this."

Lets stop acting like it.

More:
It's time to trash recycling - GreenBiz

During the last ice age some 100,000 to 15,000 years ago mammoths were widespread in the northern hemisphere from Spain to Alaska.Although some endured on a tiny island in the Arctic until 1650 BCE, most mammoths perished about 10,000 years ago during a time when they still interacted with humans. A new study that estimated a species lifespan from DNA suggests that these mammoths were most likely much older than the human hunters on their prowl, reaching up to 60 years of age.

The team of researchers at CSIRO and the University of Western Australia estimated a species lifespan based on its genome sequence. In order to unravel the lifespan clock, the researchers screened 42 genes from the DNA of 252 vertebrate species, both living and extinct. The higher the density of these genes, the higher the predicted lifespan.

When studying extinct animals, the researchers had to also use their living relatives and descendants for reference. In the case of the wooly mammoth and straight-tusked elephant, the Australian researchers performed estimations based on the genome of the modern African elephant, whose lifespan is of about 65 years.

So how long did mammoths live? The researchers estimate that they were able to live up to 60, and the same applied for straight-tusked elephants. Meanwhile, the maximum lifespan of Homo sapiens was deemed to be 38 years, according to this method. This may seem to invalidate the method seeing how the average lifespan in the United States currently is 78, but this figure actually matches other estimates of early modern human lifespans before the advent of medicine, agriculture, and sanitation.

Neanderthals and Denisovans, our close extinct relatives from the genus Homo, had a maximum lifespan of 37.8, very similar to modern humans living around the same time.

We estimated that Denisovans and Neanderthals both had a lifespan of 37.8 years. This suggests that these extinct Hominidae species had similar lifespans to their early human counterparts, the researchers wrote.

The famous Lonesome George was the last remaining Pinta tortoise (C. abingdoni) when he died in 2012. He had been living in captivity at the Charles Darwin Research Station on the Galapagos Islands since 1972 and died at age 100. Thats relatively close to the maximum lifespan estimate of 120 years found by the study.

Other extinct animals whose lifespan were calculated by the study include the little bush moa (23 years) and the passenger pigeon (28 years). The animal with the largest lifespan is the bowhead whale (268 years). However, the longest-living vertebrate may be the Greenland shark, which could live to see 512 years of age, according to a 2017 study.

The estimates for invertebrates werent nearly as accurate, possibly because they do not exhibit the targetted genes to the same extent as vertebrates.

In the future, these genes could be used to further studying aging. For instance, theres a debate among researchers as to what is the absolute limit of human longevity. The method elaborated by this study, however, cannot be used on individuals.

It cannot be used to determine the lifespan of any individual human and the purpose of this study was to determine an important parameter of ecological significance which may assist in wildlife management, said Benjamin Mayne, a scientist at the Commonwealth Scientific and Industrial Research Organisation (CSIRO) in Western Australia.

The findings appeared in the journal Scientific Reports.

Excerpt from:
DNA reveals lifespan of mammoth and other extinct animals - ZME Science

CEDAR KNOLLS, N.J., Dec. 10, 2019 /PRNewswire/ --MYOS RENS Technology, Inc. ("MYOS" or "the Company") (NASDAQ: MYOS), an advanced nutrition company and the owner of Fortetropin, a proprietary bioactive composition made from fertilized egg yolk that helps build lean muscle, announced today that it will launch its longevity business with the introduction of its Physician Muscle Health Formula at the 27thWorld Congress on Anti-Aging Medicine (https://www.a4m.com/las-vegas-december-2019.html) in Las Vegas, Nevada from December 13-15, 2019; MYOS will be in Booth #2090. Considered the largest event in anti-aging medicine, the World Congress is expected to draw approximately 4,000 Medical Professionals and 300 Exhibitors from around the world.

Earlier this year, MYOS announced that in a clinical trial involving 60-75-year-old men and women, subjects who consumed Fortetropin on a daily basis experienced an increase of approximately 15% in the rate of muscle protein synthesis when compared with subjects who received a macronutrient-matched placebo. The results from this clinical trial will be presented by its principal investigator, William J. Evans, Ph.D., Adjunct Professor of Nutrition, University of California, Berkeley at the International Conference on Frailty & Sarcopenia Research on March 11, 2020 in Toulouse, France.

Encouraged by positive results from this clinical study and previous studies showing that Fortetropin increases muscle mass and strength, MYOS decided to formally launch its longevity business by introducing its branded product, Physician Muscle Health Formula. This product will be distributed through medical practices focused on anti-aging medicine across the United States. In addition, the Company will also debut a private labeling service. This service will enable physicians to develop their own Fortetropin-based nutrition products in consultation with the Company's scientists and engineers, leveraging our portfolio of scientific research and clinical trials. Members of MYOS' scientific and business development staff will be at the Company's booth (#2090) to meet with medical professionals and discuss opportunities for collaboration.

"Fortetropin has remarkable potential to improve human longevity and we are pleased to share our advancements on improving muscle health at the upcoming World Congress on Anti-Aging Medicine later this week," commented Joseph Mannello, CEO of MYOS. "Maintaining muscle mass and health plays a vital role in supporting an excellent quality of life as we get older and has been shown in numerous respected publications to be associated with improved longevity. Muscle plays a central role in movement, energy metabolism and bone health. The beauty of MYOS' approach to addressing muscle health is that our products are all-natural nutrition products that capitalize on a patented manufacturing process and are backed by a large body of preclinical and human clinical research," added Mr. Mannello.

About MYOS RENS Technology Inc. MYOS RENS Technology Inc. (MYOS), "The Muscle Company", is a Cedar Knolls, NJ-based advanced nutrition company that develops and markets products that improve muscle health and performance. MYOS is the owner of Fortetropin, a fertilized egg yolk-based product manufactured via a proprietary process to retain and optimize its biological activity. Fortetropin has been clinically shown to increase muscle size, lean body mass and reduce muscle atrophy. MYOS believes Fortetropin has the potential to redefine existing standards of physical health and wellness. For more information, please visit http://www.myosrens.com.

About Fortetropin Fortetropin works in conjunction with your protein of choice to help your body utilize that protein more efficiently. Fortetropin is made through a patented process that maintains the vital nutrients of fertilized egg yolks to help build more lean muscle and decrease muscle loss. For more information, please visit http://www.myosrens.com.

Forward-Looking Statements Any statements in this release that are not historical facts are forward-looking statements. Actual results may differ materially from those projected or implied in any forward-looking statements. Such statements involve risks and uncertainties, including but not limited to those relating to product and customer demand, market acceptance of our products, the ability to create new products through research and development, the successful results of strategic initiatives, the success of our products, includingQurr, Yolked, MYOS Canine Muscle Formula, Physician Muscle Health Formulaand MYOS Enteral NutritionFormula, the success of our research and development, the results of the clinical evaluation ofFortetropinand its effects, the ability to enter into new partnership opportunities and the success of our existing partnerships, the ability to generate revenue and cash flow from sales of our products, the ability to increase our revenue and gross profit margins, the ability to achieve a sustainable, profitable business, the effect of economic conditions, the ability to protect our intellectual property rights, competition from other providers and products, the continued listing of our securities on the Nasdaq Stock Market, risks in product development, our ability to raise capital to fund continuing operations, and other factors discussed from time to time in our filings with the Securities and Exchange Commission. We undertake no obligation to update or revise any forward-looking statement for events or circumstances after the date on which such statement is made except as required by law.

Investor Relations: Porter LeVay & RoseMatthew Abenante, IRC, SVPPhone: 212-564-4700Email: MYOS@plrinvest.com

View original content to download multimedia:http://www.prnewswire.com/news-releases/myos-to-introduce-its-longevity-business-with-its-physician-muscle-health-formula-at-the-world-congress-on-anti-aging-medicine-in-las-vegas-december-13-15-2019-300971732.html

SOURCE MYOS RENS Technology

See the article here:
MYOS to Introduce its Longevity Business with its Physician Muscle Health Formula at the World Congress on Anti-Aging Medicine in Las Vegas December...

Hermit crabs face a uniquely competitive real estate market. They need bigger and bigger shells throughout their lives, but cant grow these homes themselves. So they rely on castoff snail shells, and are constantly on the lookout for better properties entering the market.

A study that will be published next month in the journal Physica A found that the distribution of these shells in one hermit crab population was surprisingly similar to the distribution of wealth in human societies.

That may make hermit crabs one of the first animals known to experience wealth inequality.

Ivan Chase, an emeritus professor at Stony Brook University in New York and the studys lead author, researches social systems in animals and described a phenomenon called the vacancy chain in hermit crabs in the 1980s.

When a snail dies on the beach, a crab that comes across the empty shell will inspect it closely, turning the shell over in its claws. If the crab decides this home is better than its current shell, it trades up. Another, usually smaller crab may soon find that crabs castoff and move in. Each vacancy lets about three crabs upgrade their shells, Dr. Chase said.

Dr. Chase had always wondered whether this system led to a kind of inequality among hermit crabs, with a few crustaceans hoarding the biggest homes. So in 2017, he and his co-authors started testing the idea. They gathered almost 300 hermit crabs from a Long Island beach and briefly removed the crabs from their shells. They weighed and measured each crab and its residence. Then they looked at how shells of different weights were distributed among the population.

The distribution curve they found peaked around medium-sized shells, then dropped as the shells got larger, before tapering off very gradually through the largest shells of all. This matches the shape of wealth distribution curves in many human societies.

The team used a number called the Gini coefficient to measure overall inequality among the crabs. It found a value similar to that in small human populations, though not as great as in todays large countries. The top 1 percent of hermit crabs owned only about 3 percent of the total shell weight, Dr. Chase and his co-authors noted: There are no Warren Buffetts or Jeff Bezoses. There is also no transfer of shells between crabs and their offspring.

What they discovered suggested that the distribution of shell sizes did not simply depend on crab biology. They did not find similar numbers of crabs in every size of shell, which would be expected if most crabs survive to old age (and if longevity determines shell distribution). Nor did they find that the smallest shells were most abundant, which might occur if crabs most often die young, or are preyed on at a steady rate throughout their life span.

Dr. Chase thinks the resemblance between crab and human inequality might come from similarities between crab vacancy chains and the ways people pass on wealth. While smaller crabs dont exactly inherit their wealth from bigger crabs, the largest shells are a scarce resource that only a few crabs are privileged enough to get their claws on.

Vacancy chains are just another way of transferring property, he said.

Although hes hesitant to draw any societal lessons from the crustaceans, he hopes hermit crabs can one day become a kind of model organism, like lab rats, for scientists studying wealth inequality.

The authors have nicely shown that the wealth distribution in crabs is humanlike, said Monique Borgerhoff Mulder, an anthropologist who studies human wealth inequality at the University of California, Davis. The pattern is very much like what researchers have found in small-scale human societies, both historic and contemporary, she said.

Although the transfer of wealth and property between people is an important contributor to inequality, Dr. Borgerhoff Mulder said many other factors matter too, such as social connections and individual differences in skills and education. She doubts vacancy chains are the whole story in crab society, either.

The notion that crabs can teach us about human wealth distribution may be a little preposterous, Dr. Borgerhoff Mulder added. But she said this kind of idea sharing between studies of humans and other animals is making social science, as a whole, richer.

Here is the original post:
Even Hermit Crabs Have Wealth Inequality - The New York Times

World Longevity Economy Size Projections, current USD

AI for Longevity has more potential to increase healthy Longevity in the short term than any other sector. The application of AI for Longevity will bring the greatest real-world benefits and will be the main driver of progress in the widespread extension of healthy Longevity. The global spending power of people aged 60 and over is anticipated to reach $15 trillion annually by 2020. The Longevity industry will dwarf all other industries in both size and market capitalization, reshape the globalfinancial system, and disrupt the business modelsof pension funds, insurance companies, investment banks, and entire national economies.

Longevity has become a recurring topic in analytical reports from leading financial institutions such as CitiBank, UBS Group, Julius Baer, and Barclays. At the recent AI for Longevity Summit in London, top executives from Prudential, HSBC, AXA Insurance, NVIDIA, Microsoft, Babylon Health, Insilico Medicine, Longevity.Capital, Longevity Vision Fund, Juvenescence, and Deep Knowledge Ventures came together to discuss the Longevity Industry. International policymakers and senior corporate executives shared learnings from Japan, Israel, Switzerland, the US, and the UK, and exchanged ideas on beginning to work together in a new social contract to enhance global prosperity equitably.

The 7th Continent - 1 Billion People in Retirement Globally

Switzerland is one of the most longevity progressive countries in the world with both high investment in biotechnology and the capacity to integrate AI into its economic, financial, and healthcare systems. Switzerland has the potential to be a world leader in both the Global Longevity Industry and the 4th Industrial Revolution. There are currently 100 companies, 80 investors, 50 financial companies, 35 research labs, 20 precision medicine clinics, 15 nonprofits, and 10 governmental organizations in the Swiss Longevity Industry. Switzerland is in an excellent position to retain its leading position by focusing on the optimal assembly of its existing resources to transform the challenge of demographic aging into a national asset.

Switzerland has a large aging population and Swiss investment banks are acutely aware of the oncoming demographic challenge. Switzerland is one of the most efficiently regulated and supervised financial centers in the world and has been leading transformative developments emerging from the digitalization of its banking and financial sector. Longevity-progressive countries typically have large aging populations, and aging populations have two longevity-progressive benefits: voting power and spending power.

Longevity Industry in Switzerland 2019

The digitization of finance, and novel financial systems which treat Longevity as a dividend, will play an integral role in the Longevity economy. According to a recent report by Aging Analytics Agency, Switzerland has the elements necessary to become a leading Longevity financial hub, including factors such as a lean political system that facilitates rapid implementation of integrated government programs, a strong research environment for geroscience, a strong research and business environment for digital health, and most importantly, international financial prowess.

Switzerland has the ability to develop several Longevity specific programs over the next several years. One program is a Longevity progressive pension system and insurance company ecosystem that accounts for both population aging (which threatens to destabilize the current business models of insurance companies and pension funds) and the potential for widespread healthspan extension. Another program is a national strategy for intensively developing Geroscience and FinTech to a state so advanced that it propels Switzerland into a central role in the international Longevity business ecosystem and a global leader in Longevity Finance. Switzerland is leading the digitization of financial markets and establishing itself as a catalyst for financial innovation on a global level. According to Aging Analytics Agency, 10% of all European FinTech enterprises are located in Switzerland.

Switzerland has a strong and productive geroscience community and has gained prominence among investors as a global biotech hub and hotbed of innovation. The Swiss Institute for Bioinformatics recently identified large numbers of genetic markers directly linked to human life expectancy. Switzerland is also home to the prestigious Vontobel Prize for Aging Research.

The Convergence of 5 Mega Trends

BioValley

Switzerland is situated at one end of the BioValley - one of the leading life science clusters in Europe. This cluster is unique in that it spans across three countries, Switzerland, Germany and France, and includes Basel, a global life science hub. BioValley brings together important ingredients for a successful biotech cluster including a concentration of companies, rich availability of skills, experience within Life Sciences, and a world class research base. The cluster in Switzerland has in excess of 50,000 people working in the life sciences field including 15,000 scientists. There are 600 companies in the cluster developing therapeutic, diagnostic or medical devices to address a wide range of diseases in multiple therapeutic classes. There are 100,000 students enrolled in 10 universities and research institutions including University of Basel, Max Planck Institute, and Freiburg University. The cluster has produced a number of spin-out companies supported by a financial network including both public and private financing initiatives as well as traditional venture capital and private equity. The entire process of drug development is covered in the region, from research through to clinical and drug development, and manufacturing.

Longevity AI Consortium Expands to Switzerland

Longevity AI Consortium King's College London

In November 2019, Europes firstLongevity AI Consortium(LAIC)launched at King's College London. LAIC is currently developing collaborative research projects withDynamics of Healthy Ageing (DynAge)and theDigital Society Initiative (DSI)at the University of Zurich. The research will utilize AI technologies to predict the future cognitive ability of individuals using multimodal neuroimaging and risk factor data. Academics in Zurich will work in collaboration with colleagues at the Institute of Psychiatry, Psychology, and Neuroscience at King's College London. LAIC plans to establish several collaborative projects with the University of Zurich in 2020. The joint R&D between Ageing Research at Kings and University of Zurich forms the first phase of the global Longevity AI Consortium that will eventually be extended to Israel, Singapore, Japan and the US.

The Longevity Industry

AgeTech

FinTech banks are redefining the banking industry by connecting with a new generation of mobile-first consumers. However, FinTech banks are focusing on consumers who are middle-age and younger, not on the 1 billion people in retirement and the $15 trillion dollar market opportunity. As the share of the population over 60 increases, Swiss banks are lagging behind in finding solutions for this age group. Traditional banks, as opposed to challenger banks, are taking their first steps in AgeTech and adapting their infrastructure for people over 60.

WealthTech

The WealthTech Industry refers to a new generation of financial technology companies that create digital solutions to transform the investment and asset management industry. New companies have arrived on the scene offering advice based on AI and big data, micro-investment platforms, and trading solutions based on social networks. A growing aging population is one of the main drivers of innovation in WealthTech. Financial services innovators have an opportunity to enhance the financial lives of individuals over 60 by designing new solutions and adapting existing products and services for them. This is an opportunity to implement innovations that address financial health challenges head on.

Financial Wellness

As a core component of its mission to develop Switzerland into a leading international Longevity Financial Industry hub, Longevity Swiss Foundation plans on roadmapping the development of AI Centers for Financial Wellness. Whereas the proposed AI Centers for Longevity would focus on optimizing health, these centers would focus on the application of AI to the creation of methods and technologies to promote wellness in other areas including financial wellness, continuing education, psychological well being, neuroplasticity, and active social involvement. The planned development of AI Centers for Financial Wellness will enable financial stability over extended periods of healthy Longevity for Swiss citizens.

Switzerland could become the center of the Longevity Financial Industry. Given its geographic size and its reliance on international cooperation, its function in the Longevity Industry will be as a small but important node. Due to its status as an international BioTech epicenter and its reputation as one of the most progressive countries in terms of its financial industry, the prospects for Switzerland to lead the world in the development of its Longevity Financial Industry are strong.

Today, change occurs at the intersection of two or more scientific and technological domains. We are at the beginning of a trend where the degree of complexity and the number of convergence points will increase exponentially. The convergence of AI, advanced data science, and Longevity research will accelerate important medical breakthroughs that will benefit all humans. In the next decade, the Longevity Industry will impact many areas of our lives. Longevity policies enacted by governments and changes in the global financial industry will transform society. Achieving small but practical results in Longevity distributed at scale will have enormous and multiplicative effects on society. Extending the functional lifespan of humans by just one year will decrease suffering for tens of millions of people and will improve the quality of life for billions of people.

Click the box below to preview a new book that I co-authored with my colleague Dmitry Kaminskiy entitled Longevity Industry 1.0 - Defining the Biggest and Most Complex Industry in Human History.

Visit link:
AI Will Drive The Multi-Trillion Dollar Longevity Economy - Forbes

Starting a truly innovative tech company is tough in todays world. With so many brilliant ideas available via open sourcing, it seems like every idea has been tried and tested a thousand times already.

But then you meet entrepreneurs such as Sergey Young and Jessica Maslin, whove been successful at creating something that will change our lives in the years to come. These tech luminaries have founded companies, beaten the odds and have been beyond successful in ways one can only dream of.

These men and women are obviously doing something right. Here at Technowize, we take a look at their work which has now made them household names.

A highly acclaimed technologist and investor, Sergey Young, is making longevity his lifelong mission. Young is the founder of the $100 million Longevity Vision Fund, whose goal is to accelerate the most promising longevity breakthroughs and make them accessible and affordable for all. His investment in human longevity, online education, digital healthcare, and real estate technologies spans over 20 years, making him one of the most qualified experts in this field.

Longevity Vision Fund was launched in February 2019, and in those eight months has come a long way. LVF has assembled am impressive Advisory Board of five leading longevity scientists: Vadim Gladyshev, Aubrey De Gray, Richard Faragher, Joao de Magalhaes, and Morten Scheibye-Knudsen.

Sergey Young is on the Innovation Board of XPRIZE Foundation and a Development Sponsor of Longevity XPRIZE. He is also on the Financial Advisory Board for the UKs All Party Parliamentary Group on Longevity.

Alex is Vice President and Head of the North America Strategy Office at Fujitsu, one of the world's leading information and communication technology (ICT) companies, with over $46 billion in annual revenue across more than 100 countries and 162,000 employees.

At Fujitsu, Alex Lam leads the Global Product Business strategy organization for the North American market and oversees strategic planning and business development for Fujitsu's global solutions (Enterprise, AI, SDx) with key Silicon Valley and US-based technology companies. In his role, Lam spearheaded the launch of the Fujitsu Solutions Lab, a technology partner incubator and customer POC showcase for Fujitsu's Enterprise data center solutions with innovative IT technology partners.

Alex Lam is also spearheading a team at the Fujitsu Solutions Lab that promises to revolutionize the CPU/GPU for enterprises. Fujitsu's groundbreaking technology innovation optimizes business processes and leverages the benefits of AI. Fujitsu is developing an AI-specific microprocessor called the Deep Learning Unit (DLU). The companys goal is to produce a chip that delivers 10 times better performance per watt than the competition. This is a progressive goal.

Jessica Maslin and Josh Dubon are the co-founders of Mieron, the Worlds First Virtual Reality NeuroTherapy system that helping to rehabilitate patients all over the world. MieronVR, the companys brand new virtual reality technology is being used by doctors and medical practitioners help patients rehabilitate from spinal cord and traumatic brain injuries.

The Mieron library is full of locomotive training exercises, trunk stability, strength and conditioning, upper body mobility, lower body mobility, balance and stability exercises that complement physical therapy and occupational therapy practices. The goal is to improve range of motion, execution of tasks, independence by improved mobility, and mental wellness.

There are two versions of the device currently in production, the Mieron Pro, which is used in hospitals and rehabilitation facilities, and the newly-created Mieron Go, which is a consumer version that patients can use at home.

In 2004, Brian Gill co-founded one of the worlds most successful data recovery labs with his brother Tyler and PhD Greg Piefer. The trio, along with their business partners and Gregs family, then founded Phoenix Nuclear Labs, which currently manufactures the strongest compact neutron generators in the world.

Brian Gill was on the board of PNL when it was decided to spin off medical isotope startup SHINE Medical Technologies to tackle the Mo-99 crisis. Over 56,000 American patients are imaged every day and over 30 medical procedures require Mo-99, and as of 2018 0% of the worlds supply of Mo-99 is produced in the US.

Most recently, he has teamed up with worldwide forensics thought leader Cindy Murphy to found Gillware Digital Forensics. Past successes have allowed him to make over a dozen angel investments, most recently in Medaware Systems, Pacifica Labs and Allergy Amulet.

Continue reading here:
Most Innovative People to Watch in 2020 - Technowize

KEY POINTS

The key to enjoying a longer life lies in observing a healthy lifestyle, which includes quitting or avoiding smoking, limiting alcohol intake, exercising regularly, and consuming a healthy balanced diet.

The secret to leading a healthy lifestyle is good nutrition. The foods that an individual consumes provide the body with the materials it needs to function properly. If such individual consumes too much food or types of foods that provide wrong materials to the body, they increase the risk of acquiring life-threatening diseases, which also shortens lifespan.

The Best Diet For Long Life

For the longest time, human beings have been on a quest for the best diet to help them live healthier and longer, as well as reduce the risk of deadly diseases.Recent studies have proven that the best way to achieve this is to go on a vegan diet. vegan diet to increase longevity Photo: dbreen - Pixabay

According to the World Health Organization, this type of diet can help prevent about a third of all cancer types. Studies also show those who practice this diet have lower death rates compared to meat-eaters.

The research which has been published by the JAMA Internal Medicine Journal reignited the debate on whether or not vegan diets can enhance longevity. The raging debate is happening because of conflicting evidence and medical advice on how a vegan diet can impact ones health.

Result of Increasing Animal Protein

In the said study, researchers say each three percent calories that came from plant protein was found to lower the risk of death by about 10%. The risk of heart disease death is also reduced by 12%. In comparison, increasing animal protein in the diet by around 10% increases the risk of death from all causes by about two percent.

Because of these glaring results, experts are recommending people to increase their consumption of plant-based foods like vegetables, whole grains, and fruits. Low-fat dairy products and lean protein are also recommended by experts to be included in your daily diet.

The results of these studies also suggest that consuming at least seven portions of fresh vegetables and fruits daily can help lower the risk of dying from cancer by approximately 15%.According to Dr. Mingyang Song, these studies, on the overall, support the fact that sources of dietary protein are essential for long-term health results.

View post:
Increase Longevity: Prevent Development Of Cancer By Regularly Consuming This Diet - International Business Times

In the 1960s, NASA scientists were researching many aspects of space travel for humans.

Some of the products of that research were seen by the world, such as the Apollo 11 moon landing in 1969. Others, like how to make food for astronauts out of carbon dioxide, were shelved.

But decades later, Lisa Dyson picked up where those scientists left off. A former strategy consultant with a doctorate in physics, she became interested in how to create protein in a more sustainable way and came upon the old research. She worked on the concept through Kiverdi, a company she founded, which came up with technology to develop protein from air.

Last month, Dyson announced the spinoff of a food company utilizing this technology, Air Protein. The firm, which is working on meat alternative products,expects to make an announcement about when and how they will come to market next year, she told Food Dive.

Dyson said people are becoming more aware of both the ecological impact meat production has on the planet, as well as the pressing need to better produce proteins to feed a growing population.

"This is a great opportunity to introduce an alternative that is super sustainable, significantly more sustainable than any land-based production," Dyson said."You don't need any arable land. You can keep your habitat untouched. You could scale vertically, you know, [producing food] rain or shine, day or night. In the production itself, you can produce the same amount of protein from a soy farm the size of Texas by just having an Air Protein farm the size of Walt Disney World."

Dyson hopes the new technology another way to make sustainable protein will revolutionize both the food business and the longevity of the environment.

While there is no way to get away from the deep science behind this concept, making edible protein from air sounds like science fiction.

NASA's report detailing how the technology works was published in 1967 as part of a more comprehensive study about how to support human life during a space mission longer than a year. Basically, they looked at hydrogenotrophs common microbes, some of which actually live in the human gut that can be used to turn carbon dioxide into a physical protein. NASA looked at harnessing these microbes to convert the carbon dioxide that astronauts would exhale into something they could eat.

Air Protein

Dyson, who gave a TED talk in 2016 about how this technology could work, has taken this research to the next level at her companies.They have developed fermentation vessels that can rapidly and efficiently convert gases to what looks like a protein-rich flour. She said facilities to do this are similar to breweries.

She didn't say where Air Protein's labs are located or how much equipment it has, but Kiverdi's main lab is in Pleasanton, California. Kiverdi has partnerships with other labs, and Dyson said there are several locations that will make Air Protein in the future.

The product made by these fermentation vessels is fairly versatile and has a neutral flavor, Dyson said. While it contains good nutritional credentials it has twice the protein of soy, all essential amino acids and B vitamins it can be used in many different ways. The process can help make meat analogs, pasta, cereals, shakes and protein bars, she told Food Dive.

But considering the vast environmental impact of meat and the protein needs of the human race, Dyson said meat analogs are the place to start even though the field is somewhat crowded. The company sent out pictures of a chicken substitute made from Air Protein with its press release. Dyson said they are still working on perfecting it. Air Protein is the only companywith this technology.

"These are using spices and different types and ways of techniques of taking the flour, and enriching it, and doing different things so that you can get the right texture and flavor," She said.

Air Protein is in development on many different plains, Dyson said.

She said there will be products in development under the Air Protein brand name, and she hopes to make an announcement about them next year. Meanwhile, Dyson said she is in discussion with some companies to form product partnerships, perhaps using Air Protein as an ingredient.She did not say what kinds of products those might be, but hoped to have announcements about those next year as well.

"We'll make many different types of products, and those products will have different groups of consumers that are excited about them," Dyson said. "And that's the benefit of what we're doing, is that we're not limited by one category."

"This is a great opportunity to introduce an alternative that is super sustainable, significantly more sustainable than any land-based production. You don't need any arable land. You can keep your habitat untouched. You could scale vertically, you know, [producing food] rain or shine, day or night."

Lisa Dyson

CEO, Air Protein

Dyson said she expects consumers to get excited and intrigued by Air Protein. Its target audience is any consumer, she said. The prospect of an ultra-sustainable and nutritious ingredient will make consumers want to try it, especially at a time when substitutes for animal-based products are the biggest trend in food.

Some of the NASA scientists who started the research that became both Kiverdi and Air Protein have been excited by Dyson's work, she said. Dyson has been able to blend her knowledge with their work and make air-based food a reality. And Dyson said she thinks this coupled with other sustainable practices like regenerative agriculture can be part of the solution to problems the world faces today.

"There's a range of things that need to come into play with our current food production processes becoming more efficient, becoming more sustainable," she said. "There's so many different things that we need to implement to create a more nutritious soil, healthy soil that can continue to produce crops over the ages. And produce food without the need for soil, without the need for arable land. ... I think that we need to see a plethora of ideas becoming reality."

More here:
Can Air Protein help feed and save the world at the same time? - Food Dive